Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-12)Premium Content

Isis Pharmaceuticals Inc (ISIS)

2014-12-19@19:35:51 ET
Fantastic Week for Trading (ETF)

2014-12-19@16:36:26 ET
Watch for Isis Pharmaceuticals to Potentially Pullback After Gaining 9.30% Yesterday (PSM)

2014-12-19@15:47:41 ET
Watch for Continued Gains in Shares of Isis Pharmaceuticals (ISIS) (F71)

2014-12-19@15:29:58 ET
Isis Pharmaceuticals (ISIS) Showing Bullish Technicals With Resistance At $61.27 (FBM)

2014-12-19@14:15:26 ET
Trading Higher on Heavy Volume are Shares of Isis Pharmaceuticals on 2.9x Above-Average Volume (ISIS) (F82)

2014-12-19@12:48:28 ET
IWM, HEZU: Big ETF Inflows (MNV)

2014-12-18@14:21:24 ET
Isis Pharmaceuticals Makes a Move: Up 2.3% (F77)

2014-12-18@13:41:36 ET
Potential Isis Pharmaceuticals (ISIS) Trade Has 14.96% Downside Protection (FBM)

2014-12-18@13:28:37 ET
Isis Pharmaceuticals Crosses Above its 10-day MA (ISIS) (F78)

2014-12-18@03:56:43 ET
Isis Pharmaceuticals initiates Phase I/II myotonic dystrophy type 1 study (DTM)

2014-12-17@09:49:56 ET
Isis Pharmaceuticals (ISIS) Trading Near $51.77 Support Level (FBM)

2014-12-17@08:13:33 ET
Exact Sciences has Relatively Underperformed its Peers in the Biotechnology Industry (EXAS, MNTA, ISIS, BIIB, ALXN) (F70)

2014-12-16@15:49:29 ET
Isis Pharmaceuticals (ISIS) Showing Bullish Technicals (FBM)

2014-12-16@10:07:33 ET
Uptrend Call Working As Isis Pharmaceuticals Stock Rises 66.0% (ISIS) (PSM)

2014-12-16@07:00:00 ET
Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 (PRN)